BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 6, 2019
View Archived Issues
PARP degradation joins trapping, inhibition
Read More
Tau spreads quickly but kills slowly
Read More
HLX-11 receives IND application acceptance notification from NMPA
Read More
Cartesian initiates phase I/II study of its lead CAR-T candidate, Descartes-08
Read More
eFFECTOR Therapeutics initiates early clinical study of zotatifin in advanced solid tumors
Read More
Further interim data presented from phase Ib study of EDP-1815 in patients with psoriasis
Read More
Initiation of phase Ib study of mavorixafor in severe congenital neutropenia
Read More
Regeneron provides updates on phase III development program of Libtayo in NSCLC
Read More
Daiichi Sankyo presents in vitro and in vivo data for DS-1039
Read More
NXP-031 leads to significant improvement of motor deficit in MPTP-induced mouse model of PD
Read More
Investigators design mouse model of dwarfism with PCSK1 mutation
Read More
EOLO-42016 shows promise in model of inherited ALS
Read More
Enzyme-replacement gene therapy encoding glucocerebrosidase attenuates PD phenotype
Read More
First phase I data presented for influenza vaccine OVX-836
Read More
Small molecules clear mutant Huntingtin protein
Read More
Tempest Therapeutics patents prostanoid EP2 and EP4 receptor antagonists
Read More
Incyte patent describes MAP4K1 inhibitors
Read More
TNBG-5602 induces lipid accumulation and antiproliferation in liver cancer cells through PPARgamma
Read More
Ark Biosciences reports topline proof-of-concept data for ziresovir in RSV
Read More
HitGen identifies new NTRK1 inhibitors
Read More
ATM and DNA-PK kinase inhibitors revealed in XRad Therapeutics patent
Read More
Shenzhen Targetrx Biotechnology patent details new tyrosine kinase inhibitors
Read More
4D reports preliminary phase I/II data on MRx-0518 with pembrolizumab in advanced malignancies
Read More
Dystrogen reports cardioprotective effects of DEC cells in Duchenne muscular dystrophy
Read More
BerGenBio reports updated phase II data on bemcentinib in advanced NSCLC
Read More